CRISPR/Cas9 technology: from cells to mice to stem cell therapy

CRISPR/Cas9 technology: from cells to mice to stem cell therapy

Bibliographic Details
Main Authors:	Te Riele, H, Harmsen, T, Van De Vrugt, H, Riepsaame, J
Format:	Conference item
Published:	Elsevier 2016

Similar Items

HideRNAs protect against CRISPR-Cas9 re-cutting after successful single base-pair gene editing
by: Tim J. W. Harmsen, et al.
Published: (2022-06-01)

Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair
by: Van De Vrugt, HJ, et al.
Published: (2019)

CRISPR-Cas gene perturbation and editing in human induced pluripotent stem cells
by: van Essen, M, et al.
Published: (2021)

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
by: Poojitha Pinjala, et al.
Published: (2023-05-01)

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
by: Xiaoying Chen, et al.
Published: (2024-04-01)

Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
by: Joffrey Mianné, et al.
Published: (2020-05-01)

Progress in CRISPR/Cas9 for CAR-T cell therapy of tumors
by: WU Qi, WANG Shaobo
Published: (2023-08-01)

Current advances of CRISPR-Cas technology in cell therapy
by: Hou-Yuan Qiu, et al.
Published: (2022-12-01)

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
by: Sonali P. Barwe, et al.
Published: (2020-12-01)

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
by: Hyeseon Park, et al.
Published: (2024-03-01)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
by: Jiangtao Ren, et al.
Published: (2017-04-01)

CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
by: Sasan Ghaffari, et al.
Published: (2021-08-01)

Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology
by: Kui Zhao, et al.
Published: (2023-12-01)

Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology
by: Di Zhang, et al.
Published: (2022-07-01)

Generation of an Akaluc knock-in human embryonic stem cell reporter line using CRISPR-Cas9 technology
by: Min Zhou, et al.
Published: (2021-10-01)

Generation of a MCPH1 knockout human embryonic stem cell line by CRISPR/Cas9 technology
by: Zerui Wang, et al.
Published: (2020-12-01)

Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
by: Ruiyu Tao, et al.
Published: (2024-02-01)

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
by: Celine J. Rocca, et al.
Published: (2020-06-01)

CRISPR/CAS9 SYSTEM : APPLICATIONS AND TECHNOLOGY /
by: Bertelsen, Alfred A., editor
Published: (2019)

CRISPR/Cas9 Technology and Applications in Plants
by: Emine Açar, et al.
Published: (2021-01-01)

Application of CRISPR/Cas9 technology in forages
by: Qinyan Bao, et al.
Published: (2022-12-01)

CRISPR/Cas9 Technology in Translational Biomedicine
by: Elena I. Leonova, et al.
Published: (2020-04-01)

Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
by: Sneha Gopal, et al.
Published: (2020-06-01)

Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells
by: Karen M. Chapman, et al.
Published: (2015-03-01)

Efficient CRISPR/Cas9-Mediated Gene Knockin in Mouse Hematopoietic Stem and Progenitor Cells
by: Ngoc Tung Tran, et al.
Published: (2019-09-01)

Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
by: Lingli Li, et al.
Published: (2022-03-01)

Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology
by: Weicheng Chiu, et al.
Published: (2022-04-01)

Construction of Lipopolysaccaride Binding Protein Knockout Mice Using CRISPR/Cas9 Technology
by: LI Sidi, et al.
Published: (2022-08-01)

CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection
by: Jenna Kropp Schmidt, et al.
Published: (2022-08-01)

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations
by: Ali Hazrati, et al.
Published: (2022-12-01)

Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells
by: Cynthia M. Simbulan-Rosenthal, et al.
Published: (2022-02-01)

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
by: Amandine Caillaud, et al.
Published: (2022-12-01)

High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells
by: Jared Carlson-Stevermer, et al.
Published: (2016-01-01)

An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool
by: Nasir Javaid, et al.
Published: (2022-01-01)

CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells
by: Xianglian Ge, et al.
Published: (2016-01-01)

Fluorescent tagging of endogenous proteins with CRISPR/Cas9 in primary mouse neural stem cells
by: Christopher S. Morrow, et al.
Published: (2021-09-01)

Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells
by: Rajula Elango, et al.
Published: (2022-09-01)

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
by: Ainsley Mike Antao, et al.
Published: (2020-01-01)

CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy
by: Yeshai Schary, et al.
Published: (2023-03-01)

Targeting Cancer with CRISPR/Cas9-Based Therapy
by: Katarzyna Balon, et al.
Published: (2022-01-01)